Catalog Advanced Search
169 Results
-
Includes a Live Web Event on 06/10/2025 at 11:00 AM (PDT)
Content provided by FIZE Medical (No CE credits offered)
Webinar Description:
Join top critical care experts in this FIZE Medical-sponsored webinar for a fresh look at managing unstable ICU patients using available biomarkers and real-time metrics. This webinar will cover the latest on sepsis, acute kidney injury (AKI), and hemodynamic management. Attendees will leave with a better understanding of how smarter data can drive faster, more targeted decisions when every second counts in the ICU.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by FIZE Medical for this sponsored webinar.
Joseph Carcillo, MD
Professor of Critical Care Medicine and Pediatrics
University of Pittsburgh, Department of Critical Care Medicine
Joseph Carcillo, MD, specializes in pediatric critical care medicine and pediatrics. He is certified by the American Board of Pediatrics and affiliated with UPMC Horizon, UPMC Mercy, UPMC Children's Hospital of Pittsburgh, UPMC Altoona, and UPMC Northwest. He completed his medical degree at George Washington University Medical Center, along with a residency and fellowship at Children's National Medical Center. He was previously Taskforce Chair of the ACCM Guidelines for Hemodynamic Support of Newborn and Pediatric Septic Shock, and a member of the Centers for Disease Control and Prevention (CDC) Taskforce for Definitions of Pediatric Sepsis.
Ravindra L. Mehta, MD, FACP, FRCP
Program Director - Associate Chair for Clinical Medicine, Department of Medicine
UC San Diego School of Medicine
Ravindra Mehta, MD, FACP, FRCP, is a Professor Emeritus of Medicine at the University of California San Diego where he directs the UCSD Master of Advanced Studies in Clinical Research program and is the site Principal Investigator of the NIH-funded UAB/UCSD O’Brien Center for AKI research. He chairs the annual International AKI and CRRT Conference in San Diego. Dr. Mehta is a founding member of the Acute Dialysis Quality Initiative (ADQI) and the Acute Kidney Injury Network (AKIN). His research has informed >span class="NormalTextRun SCXW217165272 BCX0"> development of the KDIGO guidelines for AKI. He has spearheaded several innovative multicenter studies on AKI including the International Society of Nephrology (ISN) AKI 0by25 project.
In 2008 Dr. Mehta was recognized by the American Nephrologists of Indian Origin and in March 2009 he was elected as a Fellow of the Royal College of Physicians in the UK. He received the ISN Bywaters Award for lifetime achievement in AKI in 2011 and in 2020 the ISN honored him by establishing a fellowship in AKI in his name.
He received the M.B.B.S. degree (1976) from the Government Medical School in Amritsar, India, and the M.D. (1979) and D.M. (1981) degrees from the Post Graduate Institute of Medical Education and Research in Chandigarh, India. He obtained his boards in Internal Medicine (1986) and Nephrology (1988) at the University of Rochester in Rochester New York. He has been on the faculty at UC San Diego since 1988.
-
This session explores the most severe forms of sepsis affecting pregnant and postpartum individuals in the U.S.
Description:
Date: May 14, 2025
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 pm PT
Maternal Sepsis Week highlights the urgency of addressing perinatal sepsis, a leading cause of maternal morbidity and mortality. This session explores the most severe forms of sepsis affecting pregnant and postpartum individuals in the U.S., examining their connection to emerging infectious threats. Current treatment guidelines will be applied to critical care scenarios, assessing the effectiveness of different management strategies. The session also focuses on proactive approaches to early detection and intervention, particularly during disease outbreaks, to improve patient outcomes and reduce complications.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the severe forms of sepsis affecting pregnant women in the US;
- Explain the relationship of severe forms of sepsis to rising endemic and pandemic diseases;
- Apply current treatment guidelines to manage cases of critical perinatal sepsis;
- Analyze the effectiveness of different treatment strategies for perinatal sepsis.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jason Vaught, MD
Associate Professor of Gynecology and Obstetrics
Johns Hopkins University School of Medicine
Jason Vaught, MD, is an Associate Professor of Gynecology and Obstetrics, and Surgery at the Johns Hopkins Hospital where he serves as a maternal fetal medicine and critical care specialist. His research studies and clinical expertise include maternal critical illness, cardiac disease in pregnancy, hypertensive disorders of pregnancy, and placenta accreta spectrum.
He has been active in the care of both pregnant and non-pregnant patients within the COVID pandemic. He also serves as the Director of Labor and Delivery at Johns Hopkins Hospital.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
- Describe the severe forms of sepsis affecting pregnant women in the US;
-
Virtual, one-day conference covering a variety of topics in antimicrobial resistance and stewardship
Description
Wednesday, April 30, 2025
According to a 2023 Sepsis Alliance survey, 85% of C-Suite executives in healthcare are concerned that antimicrobial resistance (AMR) may be increasing the potential of another pandemic. Are you ready to fight back?
Designed to explore cutting-edge solutions for antimicrobial resistance (AMR) in healthcare, the 2025 Sepsis Alliance AMR Conference provides a unique opportunity for clinicians, caregivers, patients, and the public to gain practical knowledge from experts and explore innovative approaches for combating AMR. Collaborative effort across sectors, ongoing innovation, and educational initiatives are essential to manage this intricate clinical interplay and tackle the global AMR threat.
As AMR intensifies, the risk of infections progressing to sepsis rises, leading to more challenging cases and adverse outcomes like amputations and fatalities.
We encourage you to attend sessions live, as speakers will be present to answer questions for most sessions. If you cannot attend live, sessions will be available at a later date.
FREE Nursing CE Credits Offered!
Continuing nursing education credits will be available, as will post-event access to resources, ideas, and innovations to improve antimicrobial stewardship. Sepsis Alliance is a Provider approved by the California Board of Registered Nursing, Provider Number CEP17068.
Conference Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this conference by the following sponsors:
Agenda
April 30, 2025
Time (ET) Session Title Presenter 10:00-10:15 Opening Remarks & Patient Story Leslie Green, MA, MA, MA, MA, MSW, Ed.S
Founder, Balance Amputee Education and Wellness10:15-10:50 Keynote: Antimicrobial Resistance in Nursing Homes: A Clear and Present Danger Ravina Kullar, PharmD, MPH, FIDSA
Infectious Diseases Consultant10:55-11:25 Moved to Action: Building a Patient Advocacy Group (CE Session) Christian John Lillis
Chief Executive Officer
Peggy Lillis Foundation11:30-12:00 Track 1: BD Sponsored Session: Best Practices in Blood Culture Quality and Accurate Antimicrobial Susceptibility Testing: Combating AMR and Optimizing Patient Outcomes Track 1:
Jordan Cardinal, PharmD, BCPS
Microbiology Medical Science Liaison, U.S. Region, Integrated Diagnostic Solutions, BD
Kayla Kirby, RN, MLS, ASCP
Global Medical Science Liaison,
BD Diagnostic Solutions12:00-12:15 Break 12:15-12:45 Bacteriophages: The Next Generation of Antimicrobial Agents (CE Session) Daria Van Tyne, PhD
Associate Professor of Medicine, Division of Infectious Diseases, University of Pittsburgh School of Medicine12:50-1:25 Amplifying Advocacy: Addressing Antimicrobial Resistance and Fungal Infections (CE Session) Rob Purdie
Managing Director
MyCARE1:30-2:10 Prioritizing Equity in Antimicrobial Stewardship Efforts (EASE): A Framework for Infectious Diseases Clinicians (CE Session) Jacinda (JAM) Abdul-Mutakabbir, PharmD, MPH, AAHIVP
Assistant Professor of Clinical Pharmacy, University of California San Diego2:15-2:30 Immunexpress Sponsored Session: Sepsis Probability, Antibiotic Stewardship, and Precision Medicine Using SeptiCyte RAPID Russell R. Miller III, MD, MPH, FCCM
Medical Director, Critical Care
FirstHealth of the Carolinas2:35-3:05 Development of an Immunocompromised Antimicrobial Stewardship Program Hannah Imlay, MD, MS
Associate Professor of Medicine
Director of Immunocompromised Antimicrobial Stewardship
University of Utah Health3:10-3:50 Artificial Intelligence in Infectious Diseases and Healthcare: Building Bridges to a Real-Time, Learning Health System (CE Session) Westyn Branch-Elliman, MD, MMSc, FSHEA, FIDSA
Acting Director, Health Sciences-AI; Chief, Section of Infectious Diseases; Professor of Medicine at the UCLA David Geffen School of Medicine
Veteran Affairs Digital Health Office; Greater LA VA Medical Center3:50-4:05 Break 4:05-4:30 CorMedix Sponsored Session: Reducing Risk of CRBSIs in Hemodialysis Patients: A Multi-Disciplinary Approach Celina Medina
Speaker Advocate
Payal Patel, MD
System-Wide Medical Director of Antimicrobial Stewardship, Associate Professor
Intermountain Health4:35-5:15 A Case-Based Approach to Optimizing the Treatment of Antimicrobial-Resistant Gram-Negative Infections (CE Session) Pranita Tamma, MD, MPH
Associate Professor of Pediatrics; Associate Professor, Department of Epidemiology
The Johns Hopkins University School of Medicine; The Johns Hopkins Bloomberg School of Public Health5:15-5:20 Closing Remarks Hannah Sass
Sepsis AlliancePlease feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this conference.
-
New!
A multi-part sepsis foundational curriculum designed to establish a strong knowledge of key sepsis concepts for nurses and other healthcare professionals
Description:
Sepsis remains the leading cause of death in U.S. hospitals. Rapid recognition and response are critical to improving sepsis survival rates. Research highlights the need for increased sepsis education among healthcare professionals, as targeted training has been shown to enhance recognition accuracy and reduce time to diagnosis across various patient populations. Sepsis Alliance Presents: Sepsis Fundamentals, a multi-part sepsis foundational curriculum designed to establish a strong knowledge of key sepsis concepts for nurses and other healthcare professionals, including sepsis coordinators, is designed to address this gap. This course serves as a foundation for more specialized sepsis training, ultimately contributing to improved patient outcomes.
Learning Objectives:
At the end of the Sepsis Fundamentals course, the learner should be able to:
- Describe the epidemiology of sepsis, including its prevalence, risk factors, and impact on patient outcomes;
- Recognize the early signs and symptoms of sepsis across different patient populations using clinical assessment tools;
- Differentiate sepsis from other conditions by interpreting diagnostic criteria, laboratory findings, and clinical presentations;
- Implement evidence-based treatment protocols for sepsis management, including fluid resuscitation, antimicrobial therapy, and supportive care;
- Support patient recovery by identifying post-sepsis syndrome symptoms and recommending appropriate follow-up care and rehabilitation strategies; Evaluate strategies for sepsis quality improvement and patient safety, including protocol adherence, early warning systems, and multidisciplinary teamwork.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Sepsis Alliance gratefully acknowledges Baxter for their support for the Sepsis Fundamentals program.
-
Recorded On: 04/23/2025
Learn the latest definitions, epidemiology, diagnostic advancements, and treatment protocols for pediatric sepsis.
Description:
Date: April 23, 2025
Time: 2:00 - 3:00 pm ET
Each day, over 200 pediatric cases of severe sepsis are diagnosed in the U.S., and an average of 18 children hospitalized with sepsis die. Additionally, sepsis is missed in up to 8% of children presenting to emergency departments. During this year's Pediatric Sepsis Week (April 20-26, 2025), one of the nation’s leading sepsis experts will provide an in-depth presentation on pediatric sepsis. Dr. Zimmerman will cover the latest sepsis definitions, epidemiology, and pathophysiology for pediatrics. Learners will also explore novel diagnostic advancements, sepsis treatment bundle protocols, and long-term patient outcomes.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Describe the contemporary definition of sepsis;
- Recall pediatric sepsis epidemiology;
- List novel sepsis diagnostic modalities;
- Summarize sepsis pathophysiology;
- Define sepsis bundled treatment protocols;
- State long-term sepsis mortality and morbidity.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Jerry J. Zimmerman, MD, PhD, MCCM
Faculty, Pediatric Critical Care Medicine
Seattle Children's Hospital; Harborview Medical Center University of Washington, School of Medicine
Jerry J. Zimmerman, MD, PhD, MCCM, is a Professor of Pediatrics and Anesthesiology and a senior faculty member in the Division of Pediatric Critical Care Medicine (PCCM) at Seattle Children’s Hospital and Harborview Medical Center, University of Washington School of Medicine. A leader in pediatric critical care research, he has served on numerous national committees dedicated to advancing the field. As co-editor of Pediatric Critical Care, now in its seventh edition, he brings deep expertise in PCCM’s academic landscape.
Dr. Zimmerman has been engaged in sepsis research for over 30 years, earning international recognition for his contributions. He was an inaugural satellite site principal investigator for both the Collaborative Pediatric Critical Care Research Network (CPCCRN) and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network. Recently, he chaired the Society of Critical Care Medicine’s (SCCM) Discovery Research Network.
His research leadership includes serving as principal investigator for the Life After Pediatric Sepsis Evaluation (LAPSE) study (NCT01415180), which examined long-term outcomes of children with septic shock. He also led the Genotypes and Phenotypes in Pediatric SIRS and Sepsis (GAPPSS) study, evaluating the diagnostic potential of gene mRNA expression signatures (SeptiCyte™) and proteomics in distinguishing bacterial sepsis, severe viral illness, and non-infectious systemic inflammation in critically ill children.
Dr. Zimmerman played a key role in the international PODIUM collaborative, which established modern definitions for single and multiple organ dysfunctions, and led SCCM’s Taskforce in defining the Phoenix Pediatric Sepsis Definition. He is currently a co-principal investigator for the Stress Dose Hydrocortisone in Pediatric Septic Shock (SHIPSS) interventional trial (NCT03401398). A past president of SCCM, Dr. Zimmerman has been honored with distinguished service awards from both SCCM and the American Academy of Pediatrics' Critical Care Section.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
-
Content provided by Prenosis (No CE credits offered)
Webinar Description:
Join Prenosis during this sponsored webinar to explore the impact of AI-driven diagnostics in acute care settings. Learn how FDA-authorized Sepsis ImmunoScore™ enhances traditional early warning systems by using individuals’ biology to identify patients at highest risk for sepsis, or progression to sepsis in 24 hours. Our clinical experts will discuss:
- The role of advanced biomarker analysis in improving sepsis detection and diagnosis;
- How providers can leverage AI-based technology to complement existing early warning systems and clinical decision support;
- The importance of deploying EMR-agnostic tools that integrate in existing clinical workflow;
- Use case examples illustrating the use of multi-band tests to indicate risk levels.
This sponsored webinar is ideal for healthcare professionals interested in advancing their approach to sepsis detection and management through AI-based diagnostic technology.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Prenosis for this sponsored webinar.
Robin Carver, RN, MSN, CIC
Vice President, Health System Management
Prenosis, Inc.
Robin Carver, RN, MSN, CIC, is a dynamic healthcare executive who bridges clinical care and healthcare technology, bringing over 25 years of experience in the fields of infection prevention, clinical education, and healthcare IT. Currently serving as Vice President of Health System Engagement at Prenosis, she combines her bedside nursing background with her mastery of strategic leadership to drive commercial growth and innovation in precision medicine.
As Director of Infection Prevention at WakeMed, Robin spearheaded initiatives that reduced central line infections by 87% and eliminated ventilator-associated pneumonia in the Medical ICU. Her subsequent work as VP of Member Engagement at Premier helped over 1,300 hospitals demonstrate the tangible impact of data-driven healthcare solutions and improved patient outcomes while optimizing operational efficiency.
Beyond her corporate role, Robin remains deeply committed to her local community, where she draws on her nursing expertise to help individuals and families navigate the complexities of the healthcare system. A passionate advocate for healthcare innovation, Robin combines deep clinical expertise with business acumen to help healthcare organizations navigate the evolving landscape of AI-enabled care delivery. She holds an MSN in Nursing Leadership from East Carolina University.
Jim Sianis, BS, PharmD, MBA
Executive Director, Business Development
Prenosis, Inc.
Jim Sianis, BS, PharmD, MBA, is an accomplished healthcare executive with experience spanning pharmaceutical, healthcare analytics, and diagnostic solutions. As Executive Director of Business Development at Prenosis, he leads the sales and commercialization of Sepsis ImmunoScoreTM, driving the adoption of innovative healthcare solutions grounded in data and real-world evidence.
During his 14-year tenure at Premier, Inc. Jim played a pivotal role in commercializing PINC AI's Healthcare Database, partnering with pharmaceutical, device, and diagnostic companies to create innovative solutions for unmet research needs. He also served at Merck as Medical Science Liaison supporting the anti-infective franchise, conducting high-level discussions with infectious disease thought leaders and supporting successful product launches. Jim worked as a clinical pharmacy specialist in infectious diseases at Lehigh Valley Hospital in Allentown, Pennsylvania, and served as a Hospital Corpsman and Pharmacy Technician in the United States Navy.
Jim combines deep clinical expertise with strong business acumen. His approach to business development is characterized by a strong commitment to integrity, collaboration, and strategic insight, enabling him to bridge the gap between healthcare innovation and commercial success.
-
In recognition of World Kidney Day on March 13, 2025, this webinar will explore the clinical criteria used to identify AKI in septic patients, highlighting the most relevant diagnostic markers.
Description:
Date: Tuesday, March 11
Time: 2:00 - 3:00 pm ET / 11:00 am - 12:00 PM PT
Sepsis-associated acute kidney injury (AKI) remains a critical complication with significant implications for patient outcomes. In recognition of World Kidney Day on March 13, 2025, this webinar will explore the clinical criteria used to identify AKI in septic patients, highlighting the most relevant diagnostic markers. The complex pathophysiological mechanisms driving kidney dysfunction in the context of sepsis will be examined, emphasizing the interplay between inflammation, hemodynamic instability, and cellular injury. Additionally, this webinar will help healthcare professionals better assess how AKI influences prognosis, considering key risk factors and long-term clinical outcomes.
Learning Objectives:
At the end of the activity, the learner should be able to:
- Apply clinical criteria to identify AKI in patients with sepsis;
- Analyze the key pathophysiological mechanisms contributing to AKI in patients with sepsis;
- Evaluate the prognostic implications of AKI in patients with sepsis based on clinical outcomes and risk factors.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors.
Matthieu Legrand, MD, PhD
Professor and Director of Clinical Research, Department of Anesthesia and Perioperative Medicine
University of California, San Francisco
Matthieu Legrand, MD, PhD, is a clinician scientist practicing critical care medicine and anesthesiology. His research interests focus on the development and validation of acute illness biomarkers, mostly in the setting of sepsis, septic shock, and Acute Kidney Injury, intending to improve the non-optimal performance of current diagnostic methods. He has investigated diagnostic and therapeutic interventions associated with outcomes in severely ill patients with sepsis, being the principal investigator of several clinical trials. He was Full Professor of Anesthesiology and Critical Care Medicine and Medical Director of the surgical ICU and Burn ICU at Paris Diderot University before moving to the University of California - San Francisco (UCSF) in 2019. Dr. Legrand is now Professor and Director of Clinical Research in the department of Anesthesiology and Perioperative Medicine at UCSF.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
-
Content provided by Vantive (No CE credits offered)
Webinar Description:
Endotoxin plays a prominent role in the pathogenesis of sepsis and often comes from the gut and the idea of neutralizing its detrimental capacities. All Gram-negative bacteria have a cell wall made up of endotoxins and can activate the immune system in many ways at low or toxic level. Eight out of 12 of the most dangerous bacteria cited by the World Health Organization to encourage treatment strategies are gram negative species. In addition to delving into early recognition and treatment of sepsis using the bundles, this sponsored session will explore recognition of endotoxin and innovative treatment options.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided by Vantive for this sponsored webinar.
Kathleen M. Vollman, MSN, RN, CCNS, FCCM, FCNS, FAAN
Clinical Nurse Specialist/Consultant
ADVANCING NURSING, LLC
Kathleen M. Vollman MSN, RN, CCNS, FCCM, FCNS, FAAN, is a Critical Care Clinical Nurse Specialist and Consultant. Kathleen received her BSN from Wayne State University in Detroit and her Master as Critical Care Clinical Nurse Specialist from California State University Long Beach. She has published and lectured nationally and internationally on a variety of topics including pulmonary, critical care, prevention of health care acquired injuries including pressure injury and CAUTI/CLABSIs and other HAIs, work culture, and sepsis recognition and management. She serves as a subject matter expert on these topics for the American Hospital Association and Michigan Hospital Association. From 1989 to 2003, she functioned in the role of Clinical Nurse Specialist for the Medical ICUs at Henry Ford Hospital in Detroit, Michigan. Currently, her company, ADVANCING NURSING LLC, is focused on creating empowered work environments for healthcare practitioners through the acquisition of better skills, attainment of greater knowledge, and implementation of process improvement.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
-
Hear directly from sepsis survivors about their personal experiences, and learn about the sepsis education, resources, and support services that have made a meaningful impact for survivors and their loved ones.
Description:
Original Broadcast Date: February 13, 2025
Join us during Sepsis Survivor Week 2025 to hear from sepsis survivors about their personal sepsis experiences. We’ll also share the sepsis education, resources, and support services to assist during transitions of care within the hospital, at discharge, and beyond. Attendees will learn what information and resources made a meaningful impact for these sepsis survivors and caregivers to feel supported during the acute, critical, and post-sepsis phases of their sepsis experiences, and what they wish they would have known then.
This presentation will also provide an in-depth overview of the free patient education, tools, survivor and caregiver resources, and support services Sepsis Alliance has available, with special attention on Sepsis Alliance Connect. Whether you’re a frontline healthcare professional, administrator, or sepsis advocate, this presentation will equip you with the knowledge and tools needed to make a difference and level up your sepsis patient education and transitions of care practices and programs.
Learning Objectives:
At the end of the activity, the learner should be able to:
- List key transition of care opportunities for patient education and support both during their acute care stay and critical illness, as well as post-sepsis;
- Identify strategies to support sepsis survivors and their caregivers throughout the continuum of care;
- Describe how to use available resources to plan a successful discharge process, improve long-term outcomes and reduce the need for readmission.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
Webinar Supporters:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by the Sepsis Alliance Institute sponsors.
Hailey Bain
Sepsis Survivor & Patient Partner
Sepsis Canada
Hailey is a survivor of septic shock from Toronto, Canada. Her sepsis experience was derived from appendicitis being misdiagnosed at 23 years old, which has led her to be passionate about patient advocacy and sharing her experience to improve outcomes for sepsis patients. Currently, she is a Patient Partner at Sepsis Canada and an active member of their Patient Advisory Council. Hailey also has a professional background in Human Resources across various industries, and is currently pursuing a certificate program on Critical Care and Sepsis Health Research.
Myrna Pair
Sepsis Survivor
Myrna Pair is a severe sepsis and septic shock survivor. In May 2020, emergent exploratory abdominal surgery led to removing her infected dying colon followed by construction of an ileostomy. Since then, the ostomy was reversed in 2021, open mesh surgery to repair three incisional hernias and one inguinal hernia occurred in 2024, and bowel issues continue since the ostomy reversal.
Rand Conroe
Sepsis Survivor
Rand is a sepsis survivor who previously spent 12 years in the US Army as a Russian/Korean linguist, followed by 10 years working in the defense industry as a Group Manager for General Dynamics. He has run a small chain of health clubs, owned a Country Western nightclub, and is now in the Health Care industry as the Executive Director of a Independent/Assisted Living facility in Southern Colorado.
Megan Jones
Director, Community Education and Support
Sepsis Alliance
Megan Jones joined Sepsis Alliance in 2021 after relocating from Charlotte, NC, where she was the Community Engagement and Program Coordinator for Community Building Initiative. With a background in communications, program management, and events, as well as a passion for diversity, equity, and inclusion, she has embraced the role of Senior Community and Content Manager, overseeing all of Sepsis Alliance’s Patient and Public-facing programming, including Sepsis Alliance Connect. Outside of work, Megan loves choral singing and exploring the outdoors. She enjoys exploring hiking trails in the San Diego area with her rescue dog, Shadow.
Provider approved by the California Board of Registered Nursing, Provider Number CEP17068 for 1.2 contact hours.
Other healthcare professionals will receive a certificate of attendance for 1.0 contact hour.
Medical Disclaimer
The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare professional. Sepsis Alliance recommends users consult their physician or healthcare professional regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.
-
Recorded On: 01/28/2025
Content provided by Inflammatix (No CE credits offered)
Webinar Description:
This sponsored session will present the unmet needs in assessing patients for suspected acute infection and sepsis, the promise of host response as a better approach to address these needs, and how the TriVerity™ Test System (Inflammatix, Inc.) may be used in routine care once cleared.
No CE credits are offered for this sponsored webinar. Content was determined by the sponsor.
Webinar Sponsor:
Sepsis Alliance gratefully acknowledges the support provided for this webinar by Inflammatix.
Sam Ajizian, MD
Chief Medical Officer
Inflammatix
Sam Ajizian, MD, came to Inflammatix as Chief Medical Officer after nearly 10 years at Medtronic, serving in CMO roles in the Acute Care & Monitoring businesses. He oversaw a global business serving over 115 million patients a year in over 70 countries. He is a proven global leader in the medical device community, engaging key medical societies worldwide and driving adoption of products through research, guidelines, and education. He is energized by customers and how to best meet their needs.
Please feel free to download, print, display, or share the flyer linked below. It contains a QR code that can be used to register for this webinar/course.